Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1994 1
1998 1
1999 1
2002 1
2005 1
2018 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Characteristic clinicopathologic features of adult B-cell lymphoblastic lymphoma with special emphasis on differential diagnosis with an atypical form probably of blastic lymphocytic lymphoma of intermediate differentiation origin.
Cheng AL, Su IJ, Tien HF, Wang CC, Chen YC, Wang CH. Cheng AL, et al. Cancer. 1994 Feb 1;73(3):706-10. doi: 10.1002/1097-0142(19940201)73:3<706::aid-cncr2820730334>3.0.co;2-u. Cancer. 1994. PMID: 7507799
BACKGROUND: Lymphoblastic lymphoma is typically of thymic T-cell phenotype. Lymphoblastic lymphoma of B-cell origin (B-lymphoblastic lymphoma) has been relatively poorly described. Whether B-lymphoblastic lymphoma …
BACKGROUND: Lymphoblastic lymphoma is typically of thymic T-cell phenotype. Lymphoblastic lymphoma of B- …
Valrubicin-loaded immunoliposomes for specific vesicle-mediated cell death in the treatment of hematological cancers.
Georgievski A, Bellaye PS, Tournier B, Choubley H, Pais de Barros JP, Herbst M, Béduneau A, Callier P, Collin B, Végran F, Ballerini P, Garrido C, Quéré R. Georgievski A, et al. Cell Death Dis. 2024 May 11;15(5):328. doi: 10.1038/s41419-024-06715-5. Cell Death Dis. 2024. PMID: 38734740 Free PMC article.
Following the transplantation of human pediatric B-cell acute lymphoblastic leukemia (B-ALL), T-cell acute lymphoblastic leukemia (T-ALL), or acute myeloid leukemia (AML) in immunodeficient NSG mice, we generated patient-derived xenograft (PDX) models, …
Following the transplantation of human pediatric B-cell acute lymphoblastic leukemia (B-ALL), T-cell acute lymphobla …
Treatment results of childhood acute lymphoblastic leukemia in Austria--a report of 20 years' experience.
Attarbaschi A, Mann G, Dworzak M, Urban C, Fink FM, Dieckmann K, Riehm H, Gadner H; Austrian Cooperative Study Group. Attarbaschi A, et al. Wien Klin Wochenschr. 2002 Feb 28;114(4):148-57. Wien Klin Wochenschr. 2002. PMID: 12060981
Between 1981 and 1999, 890 Austrian children with acute lymphoblastic leukemia (ALL) were treated in 5 consecutive trials using protocols from the Berlin-Frankfurt-Munster (BFM) Group. In the trials BFM-A (Austria) 81 and ALL A 84, treatment stratification was performed us …
Between 1981 and 1999, 890 Austrian children with acute lymphoblastic leukemia (ALL) were treated in 5 consecutive trials using proto …
Apoptosis-mediated inhibition of human T-cell acute lymphoblastic leukemia upon treatment with Staphylococus Aureus enterotoxin-superantigen.
Duarte A, Montagna DR, Pastorini M, Alemán M. Duarte A, et al. Front Immunol. 2023 Jun 12;14:1176432. doi: 10.3389/fimmu.2023.1176432. eCollection 2023. Front Immunol. 2023. PMID: 37377961 Free PMC article.
Patients with relapsed T cell acute lymphoblastic leukemia (T-ALL) have limited therapeutic options and poor prognosis. ...The apoptotic effect induced by SEE on Jurkat cells was therapeutically relevant. In effect, upon transplantation of Jurkat cells …
Patients with relapsed T cell acute lymphoblastic leukemia (T-ALL) have limited therapeutic options and poor prognosis. …
Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas.
Moore EM, Swerdlow SH, Gibson SE. Moore EM, et al. Am J Surg Pathol. 2018 Mar;42(3):342-350. doi: 10.1097/PAS.0000000000001015. Am J Surg Pathol. 2018. PMID: 29309299
Its role in the differential diagnosis of B-cell lymphomas, particularly in the distinction of follicular lymphoma (FL) versus marginal zone lymphoma (MZL), remains to be determined. ...MEF2B was positive in all FL and Burkitt lymphomas, 8/9 mantle cell …
Its role in the differential diagnosis of B-cell lymphomas, particularly in the distinction of follicular lymphoma (FL) versus …
Successful ambulatory treatment of Hodgkin's disease in Iranian children based on German-Austrian DAL-HD 85-90: single institutional results.
Alebouyeh M, Moussavi F, Haddad-Deylami H, Vossough P. Alebouyeh M, et al. Ann Oncol. 2005 Dec;16(12):1936-40. doi: 10.1093/annonc/mdi401. Epub 2005 Sep 12. Ann Oncol. 2005. PMID: 16157620 Free article.
Twenty nine patients (72.5%) received radiotherapy (20-25 Gy); four to the involved field (stage I), 25 to the upper mantel (stage II and also III with either residual or mediastinal mass) and three additionally to spleen and para-aortic lymph nodes. Eleven patients receiv …
Twenty nine patients (72.5%) received radiotherapy (20-25 Gy); four to the involved field (stage I), 25 to the upper mantel (stage II and al …
Amphotericin B lipid complex for the treatment of patients with acute leukemia and hepatosplenic candidiasis.
Sallah S, Semelka RC, Sallah W, Vainright JR, Philips DL. Sallah S, et al. Leuk Res. 1999 Nov;23(11):995-9. doi: 10.1016/s0145-2126(99)00129-0. Leuk Res. 1999. PMID: 10576503
Treatment of this infection can be very difficult and data on the duration of antifungal therapy are not available. We evaluated the efficacy of amphotericin B lipid complex (ABLC) for the treatment of five patients with acute leukemia and HSC. The dose of the administered …
Treatment of this infection can be very difficult and data on the duration of antifungal therapy are not available. We evaluated the …
Idarubicin combined with intermediate-dose cytosine arabinoside in the treatment of refractory acute leukemia.
Leone G, Pagano L, Marra R, Di Pietro N, Storti S, Sica S, D'Onofrio G, Ganzina F. Leone G, et al. Haematologica. 1989 Jan-Feb;74(1):57-61. Haematologica. 1989. PMID: 2498185
The most frequent non-hematological complications consisted of nausea, vomiting, diarrhea and mucositis. Four patients had hepatic and splenic microabscesses of suspected mycotic etiology, and one showed a transient cardiac arrhythmia. ...Yet the short duration of C.R. sug …
The most frequent non-hematological complications consisted of nausea, vomiting, diarrhea and mucositis. Four patients had hepatic and sp …